
New feature helps to increase data quality of high-throughput screening assays
BMG LABTECH recently launched the Advanced Assay Stability (AAS) system for the high-end microplate reader PHERAstar FSX at the SLAS 2023 in San Diego, USA.
BMG LABTECH recently launched the Advanced Assay Stability (AAS) system for the high-end microplate reader PHERAstar FSX at the SLAS 2023 in San Diego, USA.
BMG LABTECH has been awarded two brand new Seal of Quality awards, in recognition of outstanding feedback received from scientists globally.
BMG LABTECH introduced the new VANTAstar microplate reader, further expanding its range of high-quality, made-in-Germany instruments. The latest addition to the BMG LABTECH portfolio, the VANTAstar was conceived for ease-of-use and flexibility for a wide range of applications in basic research and life sciences.
BMG LABTECH will mark its 30th anniversary in January 2020 by launching an anniversary campaign that highlights the great people behind the company’s products. Started as a small one-man engineering office, BMG LABTECH is now a global manufacturer of microplate readers for the scientific community with offices in Australia, France, Japan, the UK, and the USA. The company’s success...
BMG LABTECH introduced the new CLARIOstar®Plus, further extending its range of high-quality microplate readers. The next-generation microplate reader comes with new user-friendly features and was officially introduced to the public at the SLAS conference and exhibition in Washington, D.C., in February 2019.
BMG LABTECH, a leading manufacturer of microplate readers, announces that the company has received a grant for the U.S. Patent 9,733,124, entitled “Microplate Reader with Linear Variable Filter”. The patent’s claims cover a revolutionary new type of dual monochromator technology using Linear Variable Filters (LVF) for the selection of wavelength and bandwidths. The patent provides...
BMG LABTECH developed a new gas ramping function that can fully manipulate the environment within a microplate reader, by mimicking in vitro hypoxia and ischaemia/reperfusion.